𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Lack of a pharmacokinetic interaction between mirtazapine and the newer antipsychotics clozapine, risperidone and olanzapine in patients with chronic schizophrenia

✍ Scribed by Rocco Zoccali; Maria Rosaria Muscatello; Diletta La Torre; Giovanni Malara; Andrea Canale; Domenico Crucitti; Concetta D’Arrigo; Edoardo Spina

Book ID
119583626
Publisher
Elsevier Science
Year
2003
Tongue
English
Weight
50 KB
Volume
48
Category
Article
ISSN
1043-6618

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparison between risperidone, olanzapi
Comparison between risperidone, olanzapine, and clozapine in the management of chronic schizophrenia: a naturalistic prospective 12-week observational study
✍ Rael D. Strous; Marina Kupchik; Suzana Roitman; Sima Schwartz; Noach Gonen; Robe 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 99 KB 👁 1 views

## Abstract Risperidone, olanzapine, and clozapine are three atypical antipsychotic medications commonly used in the management of chronic schizophrenia. While they offer advantages with regard to clinical efficacy and side‐effect profile, few studies have compared them in a naturalistic prospectiv

The impact upon extra-pyramidal side eff
The impact upon extra-pyramidal side effects, clinical symptoms and quality of life of a switch from conventional to atypical antipsychotics (risperidone or olanzapine) in elderly patients with schizophrenia
✍ C. W. Ritchie; E. Chiu; S. Harrigan; K. Hall; A. Hassett; S. Macfarlane; M. Mast 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 102 KB 👁 2 views

## Abstract ## Background Atypical antipsychotics are commonly used in the management of schizophrenia in late life with evidence suggesting they induce lower rates of motor disturbance, but have similar efficacy to conventional antipsychotics. Trials in the elderly have been either retrospective,